Cancer Research SABCS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Preclinical Intervention

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 201-210 of 272 total displayed.

Past content

Cancer Res.
Epidemiology and Prevention
Combinations of Tomato and Broccoli Enhance Antitumor Activity in Dunning R3327-H Prostate Adenocarcinomas
Kirstie Canene-Adams, Brian L. Lindshield, Shihua Wang, Elizabeth H. Jeffery, Steven K. Clinton, and John W. Erdman, Jr.
Cancer Res. 2007; 67: 836-843. [Abstract] [Full text] [PDF]  

Mol. Cancer Ther.
Research Articles: Therapeutics, Targets, and Development
Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-cis-retinoic acid in human malignant melanoma
Yukihiko Kato, Brenda C. Salumbides, Xiao-Fei Wang, David Z. Qian, Simon Williams, Yongfeng Wei, Tolib B. Sanni, Peter Atadja, and Roberto Pili
Mol. Cancer Ther. 2007; 6: 70-81. [Abstract] [Full text] [PDF]  

Mol. Cancer Ther.
Research Articles: Therapeutics, Targets, and Development
Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes
Melinda S. Yates, Masafumi Tauchi, Fumiki Katsuoka, Kathleen C. Flanders, Karen T. Liby, Tadashi Honda, Gordon W. Gribble, Delinda A. Johnson, Jeffrey A. Johnson, Neal C. Burton, Tomás R. Guilarte, Masayuki Yamamoto, Michael B. Sporn, and Thomas W. Kensler
Mol. Cancer Ther. 2007; 6: 154-162. [Abstract] [Full text] [PDF]  

Mol. Cancer Ther.
Research Articles: Therapeutics, Targets, and Development
Chrysin inhibits expression of hypoxia-inducible factor-1{alpha} through reducing hypoxia-inducible factor-1{alpha} stability and inhibiting its protein synthesis
Beibei Fu, Jing Xue, Zhaodong Li, Xianglin Shi, Bing-Hua Jiang, and Jing Fang
Mol. Cancer Ther. 2007; 6: 220-226. [Abstract] [Full text] [PDF]  

Mol. Cancer Ther.
Research Articles: Therapeutics, Targets, and Development
Antiproliferative activity of sulforaphane in Akt-overexpressing ovarian cancer cells
Devyani Chaudhuri, Sandra Orsulic, and Badithe T. Ashok
Mol. Cancer Ther. 2007; 6: 334-345. [Abstract] [Full text] [PDF]  

Clin. Cancer Res.
Cancer Susceptibility and Prevention
Pterostilbene, an Active Constituent of Blueberries, Suppresses Aberrant Crypt Foci Formation in the Azoxymethane-Induced Colon Carcinogenesis Model in Rats
Nanjoo Suh, Shiby Paul, Xingpei Hao, Barbara Simi, Hang Xiao, Agnes M. Rimando, and Bandaru S. Reddy
Clin. Cancer Res. 2007; 13: 350-355. [Abstract] [Full text] [PDF]  

Cancer Res.
Epidemiology and Prevention
Anti-Aromatase Activity of Phytochemicals in White Button Mushrooms (Agaricus bisporus)
Shiuan Chen, Sei-Ryang Oh, Sheryl Phung, Gene Hur, Jing Jing Ye, Sum Ling Kwok, Gayle E. Shrode, Martha Belury, Lynn S. Adams, and Dudley Williams
Cancer Res. 2006; 66: 12026-12034. [Abstract] [Full text] [PDF]  

Mol. Cancer Ther.
Research Articles: Therapeutics, Targets, and Development
Inhibition of phosphatidylinositol-3-kinase and mitogen-activated protein kinase kinase 1/2 prevents melanoma development and promotes melanoma regression in the transgenic TPRas mouse model
Barbara Bedogni, Scott M. Welford, Andrea C. Kwan, James Ranger-Moore, Kathylynn Saboda, and Marianne Broome Powell
Mol. Cancer Ther. 2006; 5: 3071-3077. [Abstract] [Full text] [PDF]  

Mol. Cancer Ther.
Research Articles: Therapeutics, Targets, and Development
Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells
Po-Lin Kuo, Ya-Ling Hsu, and Chien-Yu Cho
Mol. Cancer Ther. 2006; 5: 3209-3221. [Abstract] [Full text] [PDF]  

Mol. Cancer Ther.
Research Articles: Therapeutics, Targets, and Development
The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-{kappa}B activation through direct inhibition of I{kappa}B kinase ß
Mark M. Yore, Karen T. Liby, Tadashi Honda, Gordon W. Gribble, and Michael B. Sporn
Mol. Cancer Ther. 2006; 5: 3232-3239. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

* Collected Resources Home


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.